Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
IV Diagnostics logo — Advancing Early Cancer Detection with Circulating Tumor Cell...

IV Diagnostics

Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Management

Founded 2012 Private Equity Total: $1.19M Biotechnology, Health Care +1

General Information

Company Name IV Diagnostics
Founded Year 2012
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Platforms
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with IV Diagnostics. To contact IV Diagnostics, visit ivdiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does IV Diagnostics compare?

A PDF of IV Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting IV Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About IV Diagnostics

IV Diagnostics, founded in 2012 , is a biotechnology startup focused on advancing early cancer detection using circulating tumor cells (CTCs) for improved prognosis and disease management. The company's slogan, "Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Management," encapsulates its core mission. IV Diagnostics aims to leverage advancements in detecting and characterizing CTCs to significantly impact early cancer detection. The ability to quantify CTCs holds promise in predicting outcomes of metastatic diseases, while identifying cancer stem cells, a subset of CTCs, is crucial in detecting metastasis and disease recurrence. IV Diagnostics received a Private Equity Round investment on June 5, 2014, with Lakeshore ArchAngels and St. Louis Arch Angels as the investors. Operating at the intersection of biotechnology, healthcare, and platforms, IV Diagnostics is poised to make significant strides in the field of cancer diagnostics and disease management.

Business keywords: Cancer detection, Circulating tumor cells, Early detection, Prognosis, Disease management, Metastatic diseases, Cancer stem cells, Tumorigenic, Metastasis, Recurrence, Diagnostic targets, Bloodstream, Primary tumors, Quantifying CTCs, Characterization of CTCs

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 2
Lakeshore ArchAngels St. Louis Arch Angels
Lakeshore ArchAngels, St. Louis Arch Angels
05 Jun 2014
Venture Round $1.19M -
21 Jun 2012
Pre Seed Round Undisclosed 1
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
08 Feb 2010

IV Diagnostics Alternatives & Competitors

View All Alternatives
IV Diagnostics vs
On-Q-ity
On-Q-ity

Empowering physicians with advanced tools to improve cancer treatment decisions and enhance patient...

Series B
Biotechnology, Health Care
IV Diagnostics vs
Minerva Biotechnologies
Minerva Biotechnologies United States

We see the future first

17 employees
Biotechnology, Health Care
IV Diagnostics vs
Vortex Biosciences
Vortex Biosciences United States

Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have...

Venture round
7 employees
Biotechnology, Health Care
View all alternatives

FAQ About IV Diagnostics

Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Management
IV Diagnostics was founded in 2012.
IV Diagnostics operates in Biotechnology, Health Care and Platforms. Its work centres on Cancer detection, Circulating tumor cells, Early detection and Prognosis.
IV Diagnostics has completed 3 funding rounds, raising a total of $1.19M. The latest funding stage is Private Equity.
Top alternatives and competitors to IV Diagnostics include On-Q-ity, Minerva Biotechnologies, Vortex Biosciences, EV Therapeutics, Ikonisys. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IV Diagnostics and On-Q-ity are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for IV Diagnostics, https://bouncewatch.com/company/iv-diagnostics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes